CLINICAL PRACTICE GUIDELINE: CYP2D6 GENOTYPING FOR SAFE AND EFFICACIOUS CODEINE THERAPY

被引：0
|
作者：
Madadi, Parvaz [1 ]
Amstutz, Ursula [2 ,3 ,4 ]
Rieder, Michael [5 ,6 ,7 ]
Ito, Shinya [1 ]
Fung, Vincent [8 ,9 ,10 ,11 ]
Hwang, Soomi [3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Turgeon, Jacques [12 ,13 ]
Michaud, Veronique [12 ,13 ]
Koren, Gideon [1 ,5 ,6 ,7 ]
Carleton, Bruce C. [2 ,3 ,4 ]
机构：
[1] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Dept Pediat, Toronto, ON, Canada
[2] Univ British Columbia, Div Translat Therapeut, Dept Pediat, Vancouver, BC, Canada
[3] BC Childrens Hosp, Pharmaceut Outcomes Programme, Vancouver, BC, Canada
[4] Child & Family Res Inst, Vancouver, BC, Canada
[5] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, Clin Pharmacol, London, ON, Canada
[6] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada
[7] Univ Western Ontario, Schulich Sch Med & Dent, Dept Pediat, London, ON, Canada
[8] Prohlth Clin Res Ctr, Vancouver, BC, Canada
[9] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[10] Univ British Columbia, Fac Med, Dept Family Med, Vancouver, BC, Canada
[11] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada
[12] Ctr Hosp Univ Montreal, Univ Montreal Hosp Ctr CRCHUM, Res Ctr, Montreal, PQ, Canada
[13] Univ Montreal, Fac Pharm, Montreal, PQ, Canada
来源：
JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY | 2013年 / 20卷 / 03期
基金：
加拿大健康研究院;
关键词：
Codeine; morphine; pharmacogenetics; CYP2D6; guidelines;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This guideline is intended to provide a basis for informed decision-making regarding genetic testing to identify those individuals who will not benefit from codeine therapy, as well as those who are at an increased risk for codeine-induced toxicity. This guideline addresses the following key questions: 1) Should genetic testing for CYP2D6 be performed in patients prior to the initiation of codeine therapy? 2) How should patients with an indication for codeine therapy be managed based on their genotyping results for CYP2D6?
引用
收藏
页码：E369 / E396
页数：28
相关论文
共 50 条
  • [31] CYP2D6 genotyping in an Argentinean population.
    Florencia Gosso, Maria
    Del Federico, Melise
    Seravalie, Analia
    Sonia Baquedano, Maria
    Fay, Fabian
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Accurately genotyping CYP2D6: not for the faint of heart
    Nofziger, Charity
    Paulmichl, Markus
    PHARMACOGENOMICS, 2018, 19 (13) : 999 - 1002
  • [33] Clinical implications of CYP2D6 genotyping on tamoxifen treatment in breast cancer
    Dezentje, V. O.
    Nortier, J. W. R.
    Guchelaar, H. J.
    van de Velde, C. J. H.
    Gelderblom, H.
    EJC SUPPLEMENTS, 2008, 6 (07): : 56 - 56
  • [34] Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer
    Dezentje, Vincent O.
    Guchelaar, Henk-Jan
    Nortier, Johan W. R.
    van de Velde, Cornelis J. H.
    Gelderblom, Hans
    CLINICAL CANCER RESEARCH, 2009, 15 (01) : 15 - 21
  • [35] CYP2D6 ultrarapid metabolism and morphine/codeine ratios in blood:: Was it codeine or heroin?
    He, Y. J.
    Brockmoeller, J.
    Schmidt, H.
    Roots, I.
    Kirchheiner, J.
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2008, 32 (02) : 178 - 182
  • [36] Clinical impact of CYP2D6 polymorphism on the therapy with antidepressants and antipsychotics -: case reports of CYP2D6 poor metabolisers
    Lohmann, PL
    Frahnert, C
    Grasmäder, K
    Hiemke, C
    Laux, G
    Rao, ML
    PSYCHOPHARMAKOTHERAPIE, 2003, 10 (01): : 35 - 38
  • [37] Clinical Perspective on the Clinical Pharmacogenetics Implementation Consortium Updated 2014 Guidelines for CYP2D6 and Codeine
    Nicholson, Wayne T.
    Formea, Christine M.
    CLINICAL CHEMISTRY, 2015, 61 (02) : 319 - 321
  • [38] GENOTYPING CYP2D6 USING WHOLE GENOME GENOTYPING ARRAY DATA
    Painter, Jodie
    Grasby, Katrina
    Lind, PenelopeA.
    Medland, Sarah E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2024, 87 : 114 - 115
  • [39] Individualization of tamoxifen therapy: Much more than just CYP2D6 genotyping
    Binkhorst, Lisette
    Mathijssen, Ron H. J.
    Jager, Agnes
    van Gelder, Teun
    CANCER TREATMENT REVIEWS, 2015, 41 (03) : 289 - 299
  • [40] Functional phenotyping of the CYP2D6 probe drug codeine in the horse
    S. R. Gretler
    C. J. Finno
    P. H. Kass
    H. K. Knych
    BMC Veterinary Research, 17
12345